The estimated Net Worth of Benjamin Shaker is at least 5.12 百万$ dollars as of 14 March 2024. Benjamin Shaker owns over 274,455 units of agilon health, inc stock worth over 1,136,334$ and over the last 4 years Benjamin sold AGL stock worth over 3,984,935$.
Sign up
Benjamin Shaker AGL stock SEC Form 4 insiders trading
Benjamin has made over 22 trades of the agilon health, inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Benjamin bought 274,455 units of AGL stock worth 881,001$ on 14 March 2024.
The largest trade Benjamin's ever made was buying 274,455 units of agilon health, inc stock on 14 March 2024 worth over 881,001$. On average, Benjamin trades about 50,588 units every 35 days since 2021. As of 14 March 2024 Benjamin still owns at least 353,998 units of agilon health, inc stock.
You can see the complete history of Benjamin Shaker stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Benjamin Shaker's mailing address?
Benjamin's mailing address filed with the SEC is C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN, TX, 78723.
Insiders trading at agilon health, inc
Over the last 4 years, insiders at agilon health, inc have traded over 2,766,210,380$ worth of agilon health, inc stock and bought 408,814 units worth 1,411,859$ . The most active insiders traders include Investment Associates Ix, L...、Veeral Desai、Benjamin Shaker. On average, agilon health, inc executives and independent directors trade stock every 12 days with the average trade being worth of 4,807,999$. The most recent stock trade was executed by Benjamin Kornitzer on 14 March 2024, trading 5,434 units of AGL stock currently worth 17,443$.
What does agilon health, inc's logo look like?
Complete history of Benjamin Shaker stock trades at agilon health, inc
agilon health, inc executives and stock owners
agilon health, inc executives and other stock owners filed with the SEC include:
-
Steven Jackson Sell,
Pres, CEO & Director -
Dr. Benjamin Kornitzer M.D.,
Chief Medical & Quality Officer -
Mat Varghese,
Chief People Officer -
Ben Shaker,
Chief Markets Officer -
Claire Mulhearn,
Chief Communications & Public Affairs Officer -
Lisa Ali,
Chief Compliance Officer -
Lyn Amor Macaraeg,
VP of Legal Services -
Matthew Dale Gillmor CFA,
VP of Investor Relations -
Girish Venkatachaliah,
Chief Technology Officer -
Timothy S. Bensley,
Chief Financial Officer -
Silvana Battaglia,
Director -
Timothy Bensley,
Chief Financial Officer -
Joan Danieley,
Chief Administrative Officer -
Theodore Halkias,
Chief Business Officer -
Michelle A Gourdine,
Director -
Veeral Desai,
Chief Strategy & Dev. Officer -
Lisa Dombro,
Exper. & Innovation Officer -
Clay Richards,
Director -
Sharad Mansukani,
Director -
Benjamin Kornitzer,
Chief Med. & Quality Officer -
Benjamin Shaker,
Chief Markets Officer -
Ronald A Williams,
Director -
Glenn Sobotka,
Chief Accounting Officer -
Girish Venkatachaliah,
Chief Technology Officer -
John William Wulf,
Director -
Michael L Smith,
Director -
Karen Mc Loughlin,
Director -
Richard J Schnall,
Director -
Investment Associates Ix, L...,
-
Steven Sell,
CEO & President -
Jeffrey A. Schwaneke,
Chief Financial Officer -
Diana Mckenzie,
Director -
Priscilla Kasenchak,
Chief Accounting Officer -
Timothy Gertsch,
Chief Accounting Officer